• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然和合成查尔酮的两种重要抗癌机制。

Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.

机构信息

Department of Chemistry, Faculty of Pharmacy, Iuliu Hatieganu University, 400012 Cluj-Napoca, Romania.

Advanced Materials and Applied Technologies Laboratory, Institute of Research-Development-Innovation in Applied Natural Sciences, "Babes-Bolyai" University, Fantanele Str. 30, 400294 Cluj-Napoca, Romania.

出版信息

Int J Mol Sci. 2022 Sep 30;23(19):11595. doi: 10.3390/ijms231911595.

DOI:10.3390/ijms231911595
PMID:36232899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9570335/
Abstract

ATP-binding cassette subfamily G and tubulin pharmacological mechanisms decrease the effectiveness of anticancer drugs by modulating drug absorption and by creating tubulin assembly through polymerization. A series of natural and synthetic chalcones have been reported to have very good anticancer activity, with a half-maximal inhibitory concentration lower than 1 µM. By modulation, it is observed in case of the first mechanism that methoxy substituents on the aromatic cycle of acetophenone residue and substitution of phenyl nucleus by a heterocycle and by methoxy or hydroxyl groups have a positive impact. To inhibit tubulin, compounds bind to colchicine binding site. Presence of methoxy groups, amino groups or heterocyclic substituents increase activity.

摘要

三磷酸腺苷结合盒亚家族 G 和微管蛋白的药理学机制通过调节药物吸收和通过聚合来创建微管蛋白组装,从而降低抗癌药物的有效性。已经报道了一系列天然和合成查尔酮具有非常好的抗癌活性,其半最大抑制浓度低于 1µM。通过调节,可以观察到在第一种机制中,苯乙酮残基芳香环上的甲氧基取代基和苯核被杂环和甲氧基或羟基取代对其有积极影响。为了抑制微管蛋白,化合物与秋水仙碱结合位点结合。存在甲氧基、氨基或杂环取代基会增加活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/5c4db7eeca9e/ijms-23-11595-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/852043fd3e55/ijms-23-11595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/33775afe454f/ijms-23-11595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/7afb6cf4d851/ijms-23-11595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/8b0c6e753041/ijms-23-11595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/a3761d8fdfd7/ijms-23-11595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/83b1f36fe911/ijms-23-11595-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/2a7fe186d9b5/ijms-23-11595-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/e967c8d1a41f/ijms-23-11595-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/bc168c1ebc2b/ijms-23-11595-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/e004dc33f171/ijms-23-11595-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/927e0584353e/ijms-23-11595-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/e092f7a732c9/ijms-23-11595-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/5c4db7eeca9e/ijms-23-11595-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/852043fd3e55/ijms-23-11595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/33775afe454f/ijms-23-11595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/7afb6cf4d851/ijms-23-11595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/8b0c6e753041/ijms-23-11595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/a3761d8fdfd7/ijms-23-11595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/83b1f36fe911/ijms-23-11595-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/2a7fe186d9b5/ijms-23-11595-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/e967c8d1a41f/ijms-23-11595-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/bc168c1ebc2b/ijms-23-11595-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/e004dc33f171/ijms-23-11595-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/927e0584353e/ijms-23-11595-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/e092f7a732c9/ijms-23-11595-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c895/9570335/5c4db7eeca9e/ijms-23-11595-g013.jpg

相似文献

1
Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.天然和合成查尔酮的两种重要抗癌机制。
Int J Mol Sci. 2022 Sep 30;23(19):11595. doi: 10.3390/ijms231911595.
2
Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.以微管蛋白秋水仙碱结合位点为靶点的新型萘并查尔酮衍生物的合成、生物评价及分子模拟作为 MCF-7 乳腺癌细胞潜在的抗癌剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):139-144. doi: 10.1080/14756366.2019.1690479.
3
Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.新型含二芳基醚结构查尔酮衍生物的设计、合成、生物评价及作为潜在的抗癌药物和微管蛋白聚合抑制剂的分子对接研究。
Bioorg Chem. 2020 Jan;95:103565. doi: 10.1016/j.bioorg.2019.103565. Epub 2019 Dec 31.
4
Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.鉴定新型无毒、抗血管生成的α-氟查耳酮类化合物作为强力秋水仙碱结合位点抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):339-354. doi: 10.1080/14756366.2021.2014831.
5
The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.该化合物米利定及其衍生物通过不可逆结合到β-微管蛋白的秋水仙素结合位点来抑制微管蛋白聚合。
J Biol Chem. 2018 Jun 15;293(24):9461-9472. doi: 10.1074/jbc.RA117.001658. Epub 2018 Apr 24.
6
A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.综述:合成查耳酮衍生物作为微管蛋白聚合抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):9-38. doi: 10.1080/14756366.2021.1976772.
7
New indole-based chalconoids as tubulin-targeting antiproliferative agents.新型基于吲哚的查耳酮类化合物作为靶向微管蛋白的抗增殖剂。
Bioorg Chem. 2017 Dec;75:86-98. doi: 10.1016/j.bioorg.2017.09.005. Epub 2017 Sep 7.
8
Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.靶向秋水仙碱结合位点的杂环微管蛋白抑制剂的最新进展
Anticancer Agents Med Chem. 2016;16(10):1325-38. doi: 10.2174/1871520616666160219161921.
9
Design, synthesis, and biological evaluation of thiophene analogues of chalcones.查耳酮的噻吩类似物的设计、合成及生物学评价
Bioorg Med Chem. 2008 May 15;16(10):5367-76. doi: 10.1016/j.bmc.2008.04.026. Epub 2008 Apr 15.
10
Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents.含萘环部分查耳酮类化合物的合成、生物评价及分子对接研究。
Bioorg Chem. 2018 Feb;76:249-257. doi: 10.1016/j.bioorg.2017.11.017. Epub 2017 Nov 26.

引用本文的文献

1
Biocompatible Nitro Group-Based Photosensitizer for AIE, Hypoxia, and Photodynamic Therapy. Experimental and Theoretical Approach.用于聚集诱导发光、缺氧和光动力疗法的基于硝基基团的生物相容性光敏剂。实验与理论方法。
J Fluoresc. 2025 Apr 3. doi: 10.1007/s10895-025-04273-3.
2
Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites.一种对肝癌和人体寄生虫具有活性的新型五氟硫烷基取代查尔酮的鉴定。
Pharmaceuticals (Basel). 2025 Jan 3;18(1):50. doi: 10.3390/ph18010050.
3
()-2-Benzylidenecyclanones: Part XX-Reaction of Cyclic Chalcone Analogs with Cellular Thiols: Unexpected Increased Reactivity of 4-Chromanone- Compared to 1-Tetralone Analogs in Thia-Michael Reactions.

本文引用的文献

1
Synthesis of Chalcones Derivatives and Their Biological Activities: A Review.查尔酮衍生物的合成及其生物活性:综述
ACS Omega. 2022 Aug 2;7(32):27769-27786. doi: 10.1021/acsomega.2c01779. eCollection 2022 Aug 16.
2
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.组织驻留记忆 T 细胞和循环 T 细胞是癌症术前免疫治疗的早期应答者。
Cell. 2022 Aug 4;185(16):2918-2935.e29. doi: 10.1016/j.cell.2022.06.018. Epub 2022 Jul 7.
3
ABC transporters in breast cancer: their roles in multidrug resistance and beyond.
()-2-亚苄基环烷酮:第二十部分——环状查尔酮类似物与细胞硫醇的反应:在硫杂迈克尔反应中,与1-四氢萘酮类似物相比,4-色满酮意外地具有更高的反应活性。
Molecules. 2024 Nov 21;29(23):5493. doi: 10.3390/molecules29235493.
4
()-2-Benzylidenecyclanones: Part XIX. Reaction of ()-2-(4'-X-Benzylidene)-1-tetralones with Cellular Thiols: Comparison of Thiol Reactivities of Open-Chain Chalcones and Their Six- and Seven-Membered Cyclic Analogs.()-2-亚苄基环庚酮:第十九部分。()-2-(4'-X-亚苄基)-1-四氢萘酮与细胞硫醇的反应:开链查耳酮及其六元和七元环类似物的硫醇反应活性比较。
Int J Mol Sci. 2024 Jul 16;25(14):7773. doi: 10.3390/ijms25147773.
5
Synthesis, anticancer evaluation of novel hybrid pyrazole-based chalcones, molecular docking, DNA fragmentation, and gene expression: studies.新型基于吡唑的查耳酮杂化物的合成、抗癌评估、分子对接、DNA片段化及基因表达研究
RSC Adv. 2024 Jul 9;14(30):21859-21873. doi: 10.1039/d4ra03375b. eCollection 2024 Jul 5.
6
Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms.探索噻唑并嘧啶 AV25R:在血液肿瘤中阐明生物学活性、选择性抗癌特性以及计算机模拟的靶点和结合预测。
Molecules. 2023 Dec 15;28(24):8120. doi: 10.3390/molecules28248120.
7
2-Acetyl-5,8-dihydro-6-(4-methyl-3-pentenyl)-1,4-naphthohydroquinone-Derived Chalcones as Potential Anticancer Agents.2-乙酰基-5,8-二氢-6-(4-甲基-3-戊烯基)-1,4-萘二酚衍生查耳酮类化合物作为潜在的抗癌剂。
Molecules. 2023 Oct 19;28(20):7172. doi: 10.3390/molecules28207172.
8
Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies.查耳酮及其衍生物的抗癌活性:综述及计算机研究。
Molecules. 2023 May 10;28(10):4009. doi: 10.3390/molecules28104009.
9
()-2-Benzylidenecyclanones: Part XVIII Study the Possible Link between Glutathione Reactivity and Cancer Cell Cytotoxic Effects of Some Cyclic Chalcone Analogs A Comparison of the Reactivity of the Open-Chain and the Seven-Membered Homologs.()-2-苯亚甲基环庚酮:第十八部分 研究某些环状查尔酮类似物的谷胱甘肽反应性与癌细胞细胞毒性作用之间的可能联系 比较开链和七元同系物的反应性。
Int J Mol Sci. 2023 May 10;24(10):8557. doi: 10.3390/ijms24108557.
10
Naturally Occurring Chalcones with Aggregation-Induced Emission Enhancement Characteristics.具有聚集诱导发光增强特性的天然查耳酮。
Molecules. 2023 Apr 12;28(8):3412. doi: 10.3390/molecules28083412.
ABC 转运蛋白在乳腺癌中的作用:多药耐药及其他方面。
J Drug Target. 2022 Nov;30(9):927-947. doi: 10.1080/1061186X.2022.2091578. Epub 2022 Jun 26.
4
Synthesis and Characterization of Novel Heterocyclic Chalcones from 1-Phenyl-1-pyrazol-3-ol.新型杂环查耳酮的合成与表征:以 1-苯基-1-吡唑-3-醇为原料。
Molecules. 2022 Jun 10;27(12):3752. doi: 10.3390/molecules27123752.
5
Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer.雄激素受体基因改变与转移性前列腺癌的治疗抵抗。
Prostate. 2022 Aug;82 Suppl 1:S25-S36. doi: 10.1002/pros.24356.
6
Natural and synthetic flavonoid derivatives as new potential tyrosinase inhibitors: a systematic review.天然和合成类黄酮衍生物作为新型潜在酪氨酸酶抑制剂的系统评价
RSC Adv. 2021 Jun 23;11(36):22159-22198. doi: 10.1039/d1ra03196a. eCollection 2021 Jun 21.
7
Oxidative stress-mediated up-regulation of ABC transporters in lung cancer cells.氧化应激介导的肺癌细胞中 ABC 转运蛋白的上调。
J Biochem Mol Toxicol. 2022 Aug;36(8):e23095. doi: 10.1002/jbt.23095. Epub 2022 May 9.
8
Resistance Mechanisms to Anti-PD Cancer Immunotherapy.抗 PD 癌症免疫疗法的耐药机制。
Annu Rev Immunol. 2022 Apr 26;40:45-74. doi: 10.1146/annurev-immunol-070621-030155.
9
Synthesis and evaluation of new chalcones and oximes as anticancer agents.新型查耳酮和肟类作为抗癌剂的合成与评估
RSC Adv. 2022 Apr 1;12(17):10307-10320. doi: 10.1039/d2ra01198k. eCollection 2022 Mar 31.
10
Design, Synthesis, and Biological Evaluation of New Azulene-Containing Chalcones.新型含薁类查耳酮的设计、合成及生物学评价
Materials (Basel). 2022 Feb 22;15(5):1629. doi: 10.3390/ma15051629.